Protocol for use of Botulinum toxin A in Unlicensed Indications in Pathological Muscle Hypertonia (614)


exp date isn't null, but text field is


Use the button below to access this resource item.

Access this resource


All Primary Care
Acute / All Inpatient

Last reviewed: 16 March 2021

Next review: 01 January 2023

Author(s): Alison Barclay

Version: 2

Author Email(s): [email protected], [email protected]

Co-Author(s): Angela Lindsay

Approved By: Institute of Neurological Sciences Medical Clinical Governance Group

Document Id: 614